Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Ligand Pharmaceuticals Incorporated LGND

Healthcare Biotechnology
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:LGND)

Ligand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI® (sparsentan) in FSGS

GlobeNewswire 5 days ago

Ligand Advances Strategic Growth with Expanded and Strengthened Business Development Team

GlobeNewswire March 26, 2026

Ligand to Participate in March Investor Conferences

GlobeNewswire March 4, 2026

Ligand Reports Fourth Quarter and Full Year 2025 Financial Results

GlobeNewswire February 26, 2026

Ligand to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

GlobeNewswire February 12, 2026

Ligand to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference

GlobeNewswire February 4, 2026

Ligand Hosts 2025 Investor Day and Introduces 2026 Guidance

GlobeNewswire December 9, 2025

Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates

GlobeNewswire November 10, 2025

Ligand Reports Third Quarter 2025 Financial Results and Raises Guidance

GlobeNewswire November 6, 2025
View More News ››

Opinion & Analysis (NDAQ:LGND)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:LGND)

Next multibagger

https://stockhouse.com/news/press-releases/2019/01/31/patient-five-cancer-free-twelve-months-after-single-anti-cancer-treatment
goregil - February 14, 2019

Further Review

Although outside advisors recommended the approval of the drug to treat chronic ITP and the FDA was supposed to make a decision about it...
gossipgirl - June 20, 2008

RE: Chronic cure?

This a cure for generally the severe version, therefore at this moment its kind of lets worry about side affects later. Recently given...
amy89 - June 20, 2008

Chronic cure?

Promacta seems to be quite effective for short term use according to the FDA, but use of it to treat chronic conditions may have the side...
investology - June 12, 2008

Risky Business

I found an interesting article that talks about LGND's past performance on here: http://www.stockhouse.com/Columnists/2008...
vforvalue - June 7, 2008

well

who knows
manfrommars - October 20, 2004
View more Bullboard ››

Laser Photonics Corp.

Laser Photonics Corp.

Laser Photonics Corporation operates as a vertically integrated manufacturing company for photonics-based industrial products ...
View More »

Podcasts